Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boston Therapeutics (BTHE)

Boston Therapeutics (BTHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Boston Therapeutics 354 MERRIMACK STREET #4 LAWRENCE MA 01843 USA

www.bostonti.com P: 603-935-9799

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Boston Therapeutics, Inc. is a pharmaceutical company engaged in the development, manufacturing, and commercialization of compounds for the treatment of diabetes and inflammatory diseases. The Company focuses on glyco-pathology. Its product portfolio includes SUGARDOWN(R), PAZ320 and IPOXYN(TM). Boston Therapeutics, Inc. is based in Manchester, New Hampshire.

Key Statistics

Overview:

Market Capitalization, $K 1,111
Shares Outstanding, K 111,131
Float, K 93,739
% Float 84.35%
% of Insider Shareholders 15.65%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 10 K
Annual Net Income, $ -910 K

Growth:

1-Year Return 66.67%
3-Year Return -72.90%
5-Year Return -90.00%
5-Year Revenue Growth -90.00%
5-Year Earnings Growth 80.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 12/27/21
Earnings Per Share ttm -0.03
EPS Growth vs. Prev Qtr -100.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BTHE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -1,585.48%
Profit Margin % -9,100.00%
Debt/Equity -0.09
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -1.12
60-Month Beta 0.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.